These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18418124

  • 1. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
    Hardin DS, Ahn C, Rice J, Rice M, Rosenblatt R.
    J Investig Med; 2008 Mar; 56(3):567-73. PubMed ID: 18418124
    [Abstract] [Full Text] [Related]

  • 2. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
    Hardin DS, LeBlanc A, Para L, Seilheimer DK.
    Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery.
    Höybye C, Chandramouli V, Efendic S, Hulting AL, Landau BR, Schumann WC, Wajngot A.
    Horm Metab Res; 2008 Jul; 40(7):498-501. PubMed ID: 18393170
    [Abstract] [Full Text] [Related]

  • 8. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
    Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.
    Diabetes; 2001 Aug; 50(8):1807-12. PubMed ID: 11473042
    [Abstract] [Full Text] [Related]

  • 9. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
    Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Lévesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL, Rabasa-Lhoret R.
    J Cyst Fibros; 2007 Nov 30; 6(6):376-83. PubMed ID: 17409029
    [Abstract] [Full Text] [Related]

  • 10. Proteolysis associated with insulin resistance in cystic fibrosis.
    Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK.
    Pediatrics; 1998 Mar 30; 101(3 Pt 1):433-7. PubMed ID: 9481010
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance.
    Moran A, Milla C, Ducret R, Nair KS.
    Diabetes; 2001 Jun 30; 50(6):1336-43. PubMed ID: 11375334
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis.
    Anzeneder L, Kircher F, Feghelm N, Fischer R, Seissler J.
    Horm Metab Res; 2011 May 30; 43(5):355-60. PubMed ID: 21448848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion.
    Mangiafico SP, Lim SH, Neoh S, Massinet H, Joannides CN, Proietto J, Andrikopoulos S, Fam BC.
    J Endocrinol; 2011 Sep 30; 210(3):335-47. PubMed ID: 21700659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of pioglitazone on the liver: role of adiponectin.
    Gastaldelli A, Miyazaki Y, Mahankali A, Berria R, Pettiti M, Buzzigoli E, Ferrannini E, DeFronzo RA.
    Diabetes Care; 2006 Oct 30; 29(10):2275-81. PubMed ID: 17003306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.